Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure

The advent of disease modifying therapies (DMT) in the past two decades has been the cornerstone of successful clinical management of multiple sclerosis (MS). Despite the great strides made in reducing the relapse frequency and occurrence of new signal changes on neuroimaging in patients with relaps...

Descripción completa

Detalles Bibliográficos
Autores principales: Manouchehri, Navid, Salinas, Victor H., Rabi Yeganeh, Negar, Pitt, David, Hussain, Rehana Z., Stuve, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009145/
https://www.ncbi.nlm.nih.gov/pubmed/35432156
http://dx.doi.org/10.3389/fneur.2022.854390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009145/
https://www.ncbi.nlm.nih.gov/pubmed/35432156
http://dx.doi.org/10.3389/fneur.2022.854390

Ejemplares similares